Abstract 3371: Gene deletions in estrogen receptor positive HER2-negative breast cancer are associated with worse outcome than predicted by diagnostic-grade gene expression assaysJonathan T. Lei, Matthew J. Ellis, Brian Li et al.|Cancer Research|2025Cited by 0